Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Inventory Average: 2011-2025

Historic Inventory Average for Niagen Bioscience (NAGE) over the last 7 years, with Sep 2025 value amounting to $16.6 million.

  • Niagen Bioscience's Inventory Average rose 50.52% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year increase of 50.52%. This contributed to the annual value of $11.9 million for FY2024, which is 18.78% down from last year.
  • Niagen Bioscience's Inventory Average amounted to $16.6 million in Q3 2025, which was up 29.72% from $12.8 million recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Inventory Average peaked at $16.6 million during Q3 2025, and registered a low of $9.9 million during Q4 2024.
  • Over the past 3 years, Niagen Bioscience's median Inventory Average value was $12.3 million (recorded in 2023), while the average stood at $12.5 million.
  • Its Inventory Average has fluctuated over the past 5 years, first dropped by 27.30% in 2024, then soared by 50.52% in 2025.
  • Quarterly analysis of 5 years shows Niagen Bioscience's Inventory Average stood at $13.1 million in 2021, then climbed by 15.36% to $15.2 million in 2022, then declined by 10.44% to $13.6 million in 2023, then dropped by 27.30% to $9.9 million in 2024, then spiked by 50.52% to $16.6 million in 2025.
  • Its Inventory Average was $16.6 million in Q3 2025, compared to $12.8 million in Q2 2025 and $10.2 million in Q1 2025.